Shinichi Ohashi

Title: The Innovative Contributions of Shinichi Ohashi

Introduction

Shinichi Ohashi is a prominent inventor based in Sakura, Japan. He has made significant contributions to the field of polymeric compounds, particularly in the area of anti-tumor activity. His work has the potential to improve cancer treatment by reducing side effects associated with traditional therapies.

Latest Patents

Ohashi holds a patent for "Polymeric compounds with sustained anti-tumor activity and a method for." This novel polymeric compound features a backbone structure formed of a copolymeric moiety of maleic anhydride and divinyl ether. The compound includes pendant groups derived from anthracycline-type anti-tumor agents, such as adriamycin and daunomycin. These groups are bonded to the maleic anhydride units in the backbone structure through amide linkages. The remaining anhydride units are hydrolyzed into free acid form or a salt thereof. Both in vitro and in vivo tests indicate that the anti-tumor active pendant groups can be released sustainedly, exhibiting anti-tumor activity with significantly decreased side effects.

Career Highlights

Shinichi Ohashi serves as the Director-General of the Agency of Industrial Science and Technology. His leadership in this role has allowed him to influence the direction of research and development in industrial science, particularly in the field of innovative materials.

Collaborations

Ohashi has worked alongside notable colleagues such as Takashi Hirano and Satoshi Morimoto. Their collaborative efforts have contributed to advancements in the development of polymeric compounds and their applications in medicine.

Conclusion

Shinichi Ohashi's innovative work in polymeric compounds demonstrates his commitment to improving cancer treatment through scientific research. His contributions have the potential to make a significant impact on patient care and treatment outcomes.